Prelude Capital Management, LLC Amarin Corp Plcuk Put Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$3.64 - $7.76 $5,460 - $11,640
-1,500 Reduced 93.75%
100 $0
Q1 2020

May 15, 2020
BUY
$4.0 - $21.53 $5,200 - $27,989
1,300 Added 433.33%
1,600 $6,000
Q4 2019

Feb 14, 2020
SELL
$13.94 - $24.12 $34,850 - $60,300
-2,500 Reduced 89.29%
300 $6,000
Q4 2018

Feb 14, 2019
BUY
$12.41 - $22.98 $34,748 - $64,344
2,800 New
2,800 $38,000

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email